XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Retained earnings
Accumulated other comprehensive income (loss), net
Beginning balance, shares at Dec. 31, 2020   35,912,243    
Beginning balance at Dec. 31, 2020 $ 820,439 $ 571,021 $ 224,400 $ 25,018
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Restricted stock awards forfeited, shares   92,320    
Stock-based compensation expense 870 $ 870    
Common stock repurchased, shares   (23,246)    
Common stock repurchased (687) $ (687)    
Net income 25,344   25,344  
Other comprehensive income (loss), net of tax (11,557)     (11,557)
Cash dividends declared on common stock (7,258)   (7,258)  
Ending balance, shares at Mar. 31, 2021   35,981,317    
Ending balance at Mar. 31, 2021 827,151 $ 571,204 242,486 13,461
Beginning balance, shares at Dec. 31, 2021   35,105,779    
Beginning balance at Dec. 31, 2021 854,432 $ 551,798 293,238 9,396
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Restricted stock awards forfeited, shares   101,683    
Exercise of stock options, shares   (105,090)    
Exercise of stock options (2,652) $ (2,652)    
Stock-based compensation expense 950 $ 950    
Net income 19,757   19,757  
Other comprehensive income (loss), net of tax (43,624)     (43,624)
Cash dividends declared on common stock (7,414)   (7,414)  
Ending balance, shares at Mar. 31, 2022   35,102,372    
Ending balance at Mar. 31, 2022 $ 821,449 $ 550,096 $ 305,581 $ (34,228)